Providence Capital Advisors, LLC Gsk PLC Transaction History

Providence Capital Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$36.52 - $41.46 $182 - $207	-5 Reduced 55.56%	4 $0
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $1.56 Million - $1.82 Million	-45,403 Reduced 99.98%	9 $0
Q4 2020 Feb 11, 2021	BUY	$34.07 - $39.94 $194,301 - $227,777	5,703 Added 14.36%	45,412 $1.67 Million
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $51,486 - $58,079	1,351 Added 3.52%	39,709 $1.5 Million
Q2 2020 Aug 04, 2020	SELL	$37.87 - $43.58 $15,110 - $17,388	-399 Reduced 1.03%	38,358 $1.57 Million
Q1 2020 May 12, 2020	BUY	$32.47 - $48.83 $51,302 - $77,151	1,580 Added 4.25%	38,757 $1.47 Million
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $25,368 - $29,143	604 Added 1.65%	37,177 $1.75 Million
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $14,525 - $15,623	359 Added 0.99%	36,573 $1.56 Million
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $492,184 - $533,408	12,492 Added 52.66%	36,214 $1.45 Million
Q1 2019 May 08, 2019	BUY	$38.57 - $42.69 $26,343 - $29,157	683 Added 2.96%	23,722 $991,000
Q4 2018 Feb 01, 2019	BUY	$37.8 - $42.69 $29,786 - $33,639	788 Added 3.54%	23,039 $880,000
Q3 2018 Nov 08, 2018	BUY	$39.75 - $42.69 $12,243 - $13,148	308 Added 1.4%	22,251 $894,000
Q2 2018 Aug 08, 2018	BUY	$39.61 - $42.76 $17,903 - $19,327	452 Added 2.1%	21,943 $885,000
Q1 2018 May 10, 2018	BUY	$36.18 - $40.15 $57,598 - $63,918	1,592 Added 8.0%	21,491 $840,000
Q4 2017 Feb 12, 2018	BUY	$35.34 - $41.9 $703,230 - $833,768	19,899	19,899 $706,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $71.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Capital Advisors, LLC with notifications on news.